PACINI, FURIO
 Distribuzione geografica
Continente #
NA - Nord America 1.003
AS - Asia 490
EU - Europa 387
SA - Sud America 31
AF - Africa 25
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.953
Nazione #
US - Stati Uniti d'America 968
CN - Cina 245
IT - Italia 84
JP - Giappone 63
DE - Germania 48
GB - Regno Unito 48
IE - Irlanda 48
FR - Francia 45
VN - Vietnam 35
CA - Canada 32
IN - India 32
SE - Svezia 26
KR - Corea 23
HK - Hong Kong 21
TR - Turchia 16
BR - Brasile 13
AU - Australia 12
HU - Ungheria 12
NL - Olanda 12
PL - Polonia 12
MY - Malesia 10
ZA - Sudafrica 10
ES - Italia 9
IR - Iran 9
RU - Federazione Russa 9
CZ - Repubblica Ceca 8
IL - Israele 8
TW - Taiwan 8
EG - Egitto 7
SA - Arabia Saudita 7
CO - Colombia 6
GR - Grecia 5
BE - Belgio 4
CL - Cile 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
RO - Romania 4
TH - Thailandia 4
DZ - Algeria 3
FI - Finlandia 3
ID - Indonesia 3
MX - Messico 3
NO - Norvegia 3
PE - Perù 3
TN - Tunisia 3
AT - Austria 2
EC - Ecuador 2
KE - Kenya 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CH - Svizzera 1
EE - Estonia 1
EU - Europa 1
PY - Paraguay 1
RS - Serbia 1
SG - Singapore 1
VE - Venezuela 1
Totale 1.953
Città #
Fairfield 118
Ashburn 64
Buffalo 61
Houston 61
Seattle 59
Woodbridge 57
Beijing 44
Santa Cruz 44
Cambridge 43
Dublin 43
Siena 43
Shanghai 37
Wilmington 36
Dong Ket 32
Stockholm 26
Tokyo 25
Guangzhou 24
Ann Arbor 22
Hangzhou 20
New York 15
Boston 14
Los Angeles 13
Southend 13
Budapest 12
Boardman 10
Chicago 10
London 10
Changsha 9
Fremont 9
Las Vegas 9
Nanjing 9
Phoenix 9
Bengaluru 8
San Diego 8
Bethesda 7
Hefei 7
Henderson 7
Redmond 7
University Park 7
Absecon 6
Baran 6
Erlangen 6
Hyderabad 6
Lake Forest 6
Riva 6
Setagaya-ku 6
Athens 5
Bangalore 5
Cairo 5
Central 5
Central District 5
Chengdu 5
Clearwater 5
Liverpool 5
Muizenberg 5
Munich 5
Ottawa 5
San Francisco 5
Wuhan 5
Atlanta 4
Berlin 4
Bogotá 4
Dallas 4
Durham 4
Esneux 4
Fukuoka 4
Izmir 4
Jinan 4
Kashiwa 4
Manaia 4
Milan 4
Montréal 4
Nanchang 4
Riyadh 4
Seoul 4
Shenyang 4
Tianjin 4
Ankara 3
Bangkok 3
Birmingham 3
Brescia 3
Durban 3
Fukushima 3
Hamilton 3
Hanoi 3
Hilden 3
Hyde 3
Kenner 3
Lake Worth 3
Lima 3
Lucca 3
Madison 3
Madrid 3
Minato-ku 3
Okayama 3
Oxford 3
Paris 3
Port Moody 3
Potomac 3
Provo 3
Totale 1.300
Nome #
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?, file e0feeaa6-44e5-44d2-e053-6605fe0a8db0 668
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment, file e0feeaa6-4a6d-44d2-e053-6605fe0a8db0 307
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer, file e0feeaa6-494b-44d2-e053-6605fe0a8db0 258
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma, file e0feeaa6-447c-44d2-e053-6605fe0a8db0 184
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer, file e0feeaa6-4845-44d2-e053-6605fe0a8db0 145
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology, file e0feeaa6-447b-44d2-e053-6605fe0a8db0 120
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma, file e0feeaa8-0491-44d2-e053-6605fe0a8db0 101
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer, file e0feeaab-ba28-44d2-e053-6605fe0a8db0 88
null, file e0feeaa6-4a04-44d2-e053-6605fe0a8db0 75
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cute-off level for RET/PTC rearrangements., file e0feeaa7-e853-44d2-e053-6605fe0a8db0 30
Management of advanced medullary thyroid cancer, file e0feeaa6-4bc9-44d2-e053-6605fe0a8db0 11
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients, file e0feeaa8-3630-44d2-e053-6605fe0a8db0 4
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology., file e0feeaa4-c767-44d2-e053-6605fe0a8db0 3
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer, file e0feeaa8-09d0-44d2-e053-6605fe0a8db0 3
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor, file e0feeaa9-db0e-44d2-e053-6605fe0a8db0 3
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients, file e0feeaa4-fa8a-44d2-e053-6605fe0a8db0 2
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias, file e0feeaa5-0037-44d2-e053-6605fe0a8db0 2
Screening of thyroid nodules by serum calcitonin measurements: why not?, file e0feeaa5-06a7-44d2-e053-6605fe0a8db0 2
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients, file e0feeaa5-06ab-44d2-e053-6605fe0a8db0 2
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group., file e0feeaa5-a270-44d2-e053-6605fe0a8db0 2
null, file e0feeaa4-ca5d-44d2-e053-6605fe0a8db0 1
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer., file e0feeaa4-e4f0-44d2-e053-6605fe0a8db0 1
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study., file e0feeaa4-ffec-44d2-e053-6605fe0a8db0 1
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer., file e0feeaa4-fff0-44d2-e053-6605fe0a8db0 1
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up., file e0feeaa4-fff1-44d2-e053-6605fe0a8db0 1
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, file e0feeaa5-02ad-44d2-e053-6605fe0a8db0 1
Approach to and treatment of differentiated thyroid carcinoma, file e0feeaa5-02b0-44d2-e053-6605fe0a8db0 1
Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients, file e0feeaa5-058b-44d2-e053-6605fe0a8db0 1
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update, file e0feeaa5-0786-44d2-e053-6605fe0a8db0 1
New insight in the follow-up strategies of differentiated thyroid cancer, file e0feeaa5-0869-44d2-e053-6605fe0a8db0 1
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population., file e0feeaa5-1137-44d2-e053-6605fe0a8db0 1
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa, file e0feeaa5-2629-44d2-e053-6605fe0a8db0 1
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes, file e0feeaa8-507e-44d2-e053-6605fe0a8db0 1
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules, file e0feeaa9-7494-44d2-e053-6605fe0a8db0 1
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients, file e0feeaaa-29dd-44d2-e053-6605fe0a8db0 1
Totale 2.025
Categoria #
all - tutte 4.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019183 0 0 0 0 0 0 0 0 26 33 62 62
2019/2020449 36 33 39 41 40 30 36 40 42 40 29 43
2020/2021356 15 47 16 24 48 37 25 20 19 40 19 46
2021/2022390 27 22 26 54 32 19 29 19 49 20 69 24
2022/2023358 19 17 51 40 21 42 23 34 25 36 31 19
2023/2024235 47 32 26 18 38 21 39 13 1 0 0 0
Totale 2.025